Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Recent findings in breast cancer described by researchers from University of California
March 5th, 2009
" Following the release of the 2002 report of the Women's Health Initiative ( WHI) trial of estrogen plus progestin, the use of menopausal hormone therapy in the United States decreased substantially. Subsequently, the incidence of breast cancer also dropped, suggesting a cause- and- effect relation between hormone treatment and breast cancer," scientists in the United States report. "However, the cause of this decrease remains controversial. We analyzed the results of the WHI randomized clinical trial - in which one study group received 0.625 mg of conjugated equine estrogens plus 2.5 mg of medroxyprogesterone acetate daily and another group received placebo - and...
Source: Women's Health Weekly (2009-03-05)
|
